Name | APTEKA, ZAO |
|---|
INN | 6926002341 |
|---|
KPP | 692601001 |
|---|
OGRN | 1046906007191 |
|---|
OKPO | 74386469 |
|---|
Address | 171470, Tverskaya oblast', Kesova gora, ul. Pochtovaya, d. 7B |
|---|
Phone | 274 21231 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) |
Registration date | 04.11.2004 |
|---|
Registering department | Mezhrayonnaya inspektsiya Ministerstva Rossiyskoy Federatsii po nalogam i sboram N4 po Tverskoy oblasti |
|---|
|
APTEKA, ZAO (Tver Oblast; INN 6926002341) was registered on 4 Nov 2004. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of APTEKA, ZAO - Closed joint-stock companies. Form of ownership of APTEKA, ZAO - Private property. Principal activities of APTEKA, ZAO: retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2022
Net profit (RAS) of APTEKA, ZAO grew over 2022 by 42.00% to 1.93 million RUB from 1.36 million RUB over 2021, the company informed. Revenue increased in the accounting period by 9.15% to 55.49 million RUB from 50.84 million RUB over 2021; cost of goods sold grew by 9.36% to 45.58 million RUB from 41.68 million RUB; sales profit went up by 11.79% to 3.07 million RUB from 2.75 million RUB. 2020
Net profit (RAS) of APTEKA, ZAO grew over 2020 by 7.10% to 2.82 million RUB from 2.64 million RUB over 2019, the company informed. Revenue increased in the accounting period by 28.80% to 45.46 million RUB from 35.29 million RUB over 2019; cost of goods sold grew by 29.80% to 37.54 million RUB from 28.92 million RUB; sales profit went up by 33.43% to 3.52 million RUB from 2.64 million RUB. 2019
Net profit (RAS) of APTEKA, ZAO grew over 2019 by 30.51% to 2.64 million RUB from 2.02 million RUB over 2018, the company informed. Revenue increased in the accounting period by 7.24% to 35.29 million RUB from 32.91 million RUB over 2018; cost of goods sold grew by 7.58% to 28.92 million RUB from 26.89 million RUB; sales profit went up by 30.51% to 2.64 million RUB from 2.02 million RUB. 2018
Net profit (RAS) of APTEKA, ZAO dropped in 2018 by 2.27% to 2.02 million RUB from 2.07 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 10.27% to 32.91 million RUB from 29.84 million RUB over 2017; cost of goods sold grew by 10.81% to 26.89 million RUB from 24.26 million RUB; sales profit fell by 2.27% to 2.02 million RUB from 2.07 million RUB. 2017
Net profit (RAS) of APTEKA, ZAO dropped in 2017 by 31.68% to 2.07 million RUB from 3.02 million RUB over the same period in 2016, the company informed. Revenue increased in the accounting period by 7.79% to 29.84 million RUB from 27.69 million RUB over 2016; cost of goods sold grew by 7.79% to 24.26 million RUB from 22.51 million RUB; sales profit fell by 31.68% to 2.07 million RUB from 3.02 million RUB. 2016
Net profit (RAS) of APTEKA, ZAO grew over 2016 by 25.74% to 3.02 million RUB from 2.41 million RUB over 2015, the company informed. Revenue increased in the accounting period by 3.62% to 27.69 million RUB from 26.72 million RUB over 2015; cost of goods sold grew by 3.62% to 22.51 million RUB from 21.72 million RUB; sales profit went up by 25.74% to 3.02 million RUB from 2.41 million RUB. 2014
Net profit (RAS) of Apteka, ZAO dropped in 2014 by 21.25% to 2.05 million RUB from 2.61 million RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 5.77% to 22.86 million RUB from 21.61 million RUB over 2013; cost of goods sold grew by 6.19% to 18.66 million RUB from 17.57 million RUB; sales profit fell by 21.25% to 2.05 million RUB from 2.61 million RUB. 2013
Net profit (RAS) of Apteka, ZAO grew over 2013 by 37.43% to 2.61 million RUB from 1.90 million RUB over 2012, the company informed. Revenue increased in the accounting period by 23.24% to 21.61 million RUB from 17.54 million RUB over 2012; cost of goods sold grew by 23.18% to 17.57 million RUB from 14.27 million RUB; sales profit went up by 37.43% to 2.61 million RUB from 1.90 million RUB. 2012
Net profit (RAS) of Apteka, ZAO grew over 2012 by 25.63% to 1.90 million RUB from 1.51 million RUB over 2011, the company informed. Revenue increased in the accounting period by 10.69% to 17.54 million RUB from 15.84 million RUB over 2011; cost of goods sold grew by 9.11% to 15.64 million RUB from 14.33 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|